Department of Genetics, Development, and Cell Biology, Iowa State University, Ames, IA, United States; Immunobiology Graduate Program, Iowa State University, United States; Neuroscience Graduate Program, Iowa State University, United States.
Immunobiology Graduate Program, Iowa State University, United States; Department of Kinesiology, Iowa State University, United States.
Neurobiol Dis. 2019 Jan;121:1-16. doi: 10.1016/j.nbd.2018.09.013. Epub 2018 Sep 12.
Parkinson's disease (PD) is a neurodegenerative disorder characterized by accumulation of misfolded α-synuclein within the central nervous system (CNS). Visual problems in PD patients are common, although retinal pathology associated with PD is not well understood. The purpose of this study was to investigate retinal pathology in a transgenic mouse model (TgM83) expressing the human A53T α-synuclein mutation and assess the effect of α-synuclein "seeding" on the development of retinal pathology. Two-month-old TgM83 mice were intracerebrally inoculated with brain homogenate from old (12-18 months) TgM83 mice. Retinas were then analyzed at 5 months of age. We analyzed retinas from 5-month-old and 8-month-old uninoculated healthy TgM83 mice, and old (12-18 months) mice that were euthanized following the development of clinical signs. Retinas of B6C3H mice (genetic background of the TgM83 mouse) served as control. We used immunohistochemistry and western blot analysis to detect accumulation of α-synuclein, pTau, inflammation, changes in macroautophagy, and cell death. Raman spectroscopy was used to test the potential to differentiate between retinal tissues of healthy mice and diseased mice. This work demonstrates retinal changes associated with the A53T mutation. Retinas of non-inoculated TgM83 mice had accumulation of α-synuclein, "pre-tangle" tau, activation of retinal glial cells, and photoreceptor cell loss by 8 months of age. The development of these changes is accelerated by inoculation with brain homogenate from clinically ill TgM83 mice. Compared to non-inoculated 5-month-old TgM83 mice, retinas of inoculated 5-month-old mice had increased accumulation of α-synuclein (pSer129) and pTau proteins, upregulated microglial activation, and dysregulated macroautophagy. Raman spectroscopic analysis was able to discriminate between healthy and diseased mice. This study describes retinal pathology resulting from the A53T mutation. We show that seeding with brain homogenates from old TgM83 mice accelerates retinal pathology. We demonstrate that Raman spectroscopy can be used to accurately identify a diseased retina based on its biochemical profile, and that α-synuclein accumulation may contribute to accumulation of pTau proteins, neuroinflammation, metabolic dysregulation, and photoreceptor cell death. Our work provides insight into retinal changes associated with Parkinson's disease, and may contribute to a better understanding of visual symptoms experienced by patients.
帕金森病(PD)是一种神经退行性疾病,其特征是中枢神经系统(CNS)中错误折叠的α-突触核蛋白积累。PD 患者存在常见的视觉问题,但与 PD 相关的视网膜病理学尚不清楚。本研究旨在研究表达人类 A53T α-突触核蛋白突变的转基因小鼠模型(TgM83)中的视网膜病理学,并评估α-突触核蛋白“播种”对视网膜病理学发展的影响。将 2 个月大的 TgM83 小鼠脑内接种来自老年(12-18 个月)TgM83 小鼠的脑匀浆。然后在 5 个月大时分析视网膜。我们分析了未接种的 5 个月大和 8 个月大的健康 TgM83 小鼠的视网膜,以及在出现临床症状后安乐死的老年(12-18 个月)小鼠的视网膜。B6C3H 小鼠(TgM83 小鼠的遗传背景)的视网膜作为对照。我们使用免疫组织化学和 Western blot 分析来检测α-突触核蛋白、pTau、炎症、巨自噬变化和细胞死亡的积累。拉曼光谱用于测试区分健康小鼠和患病小鼠视网膜组织的潜力。这项工作证明了与 A53T 突变相关的视网膜变化。未接种的 TgM83 小鼠的视网膜在 8 个月大时积累了α-突触核蛋白、“预缠结”tau、视网膜神经胶质细胞激活和光感受器细胞丢失。用来自临床患病 TgM83 小鼠的脑匀浆接种可加速这些变化的发展。与未接种的 5 个月大的 TgM83 小鼠相比,接种的 5 个月大的小鼠的视网膜中α-突触核蛋白(pSer129)和 pTau 蛋白积累增加,小胶质细胞激活上调,巨自噬失调。拉曼光谱分析能够区分健康和患病小鼠。本研究描述了由 A53T 突变引起的视网膜病理学。我们表明,用来自老年 TgM83 小鼠的脑匀浆接种可加速视网膜病理学的发展。我们证明拉曼光谱可以用于根据其生化特征准确识别患病的视网膜,并且α-突触核蛋白的积累可能导致 pTau 蛋白、神经炎症、代谢失调和光感受器细胞死亡的积累。我们的工作提供了对帕金森病相关视网膜变化的深入了解,并可能有助于更好地理解患者的视觉症状。